T. Shneyder

A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial

C. Klade, H. Gisslinger, N. Tzvetkov, 2019, British journal of haematology.

Contrasts between mucormycosis and aspergillosis in oncohematological patients.

B. Afanasyev, O. Shadrivova, S. Ignatyeva, 2019, Medical mycology.

INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS

B. Afanasyev, O. Shadrivova, S. Ignatyeva, 2018, Oncohematology.

Toxic and infectious lung injury differential diagnosis specifics in oncohematological patients

V. Trofimov, L. Stel'makh, E. Morozova, 2023, Oncohematology.